
Lantéri-Minet M, Duru G, Mudge M, Cottrell S. 2011. Quality of life impairment, disability, and economic burden associated with chronic daily headache, focussing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. doi: 10.1177/0333102411398400.
Bloch M, Farris M, Tilden D, Gowers A, Cunningham N. 2010. Triple-class HIV antiretroviral therapy failure in an Australian primary care setting. Sex Health. 7(1):17–24.
Saridogan E, Tilden D, Sykes D, Davis N, Subramanian D. 2010. Cost-analysis comparison of outpatient see-and-treat hysteroscopy service with other hysteroscopy service models. J Minim Invasive Gynecol. 17(4):518–25.
Tilden D, Jackson D, LeReun C, Harvey C, Price B, Chaudhary M, van Bavel J. 2010. A modelled economic evaluation of raltegravir compared to standard practice in Australia for treatment-naïve patients with HIV. ISPOR 4th Asia Pacific Congress. 5–7 September 2010. Phuket, Thailand. BEST POSTER RESEARCH PRESENTATION AWARD WINNER
Cottrell S, LeReun C, Robinson P, Tilden D. 2009. Preference and willingness-to-pay study to assess the value of an anticoagulation therapy modelled on dabigatran etexilate using discrete choice analysis: A UK pilot study of atrial fibrillation patients naïve to warfarin. ISPOR 12th Annual European Congress. 24–27 October 2009, Paris, France. Poster presentation.
Jackson D, Lee J, Adams J, Gordois A. 2009. Long term cost-effectiveness of docetaxel plus cyclophosphamide compared to doxorubicin plus cyclophosphamide as adjuvant treatment for women with operable breast cancer. ISPOR 12th Annual European Congress. 24–27 October 2009, Paris, France. Poster presentation.
Robinson P, Cottrell S, Tilden D, LeReun C. 2009. Preference and willingness-to-pay study to assess the value of an anticoagulation therapy modelled on dabigatran etexilate using discrete choice analysis: A UK pilot study of atrial fibrillation patients receiving warfarin. ISPOR 12th Annual European Congress. 24–27 October 2009, Paris, France. Poster presentation.
Tilden D, Lee J. 2009. Cost-effectiveness of extended versus nonextended prophylaxis with enoxaparin in high-risk surgical patients in Australia. ISPOR 12th Annual European Congress. 24–27 October 2009, Paris, France. Poster presentation.
Walker M, Lykopoulos K, McLeod E, Cottrell S, Christova L. 2009. Impact of brain metastases on health care costs in metastatic breast cancer: A multi-national study. J Clin Oncol, ASCO Annual Meeting Proceedings. 27(15S):6555.
Bhatti T, Makino K, Guarnieri C, Gordois A, Cotter T, Perez D, Bishop J, Glass P. 2008. Cost-effectiveness analysis of smoking cessation pharmacotherapies in Australia. ISPOR 3rd Asia-Pacific Conference, Seoul, Korea, September 2008. Poster presentation.
Bishop J, Glass P, Tracey E, Hardy M, Warner K, Makino K, Gordois A, Wilson J, Guarnieri C, Feng J, Sartori L. 2008. Health economics review of bowel cancer screening in Australia. Cancer Institute NSW, August 2008.
Cottrell S, Tilden D, Robinson P, Bae J, Arellano J, Edgell E, Aristides M, Boye KS. 2008. A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom. Val Health. 11(3): 376–388.
Cottrell S, Walker M, Scheijbeler H, Christova L, Hertel N, Hass B, Behrens M, Roux E, Amonkar M, Aristides M. 2008. Impact of brain metastases on health care costs associated with the management of patients with metastatic breast cancer in France and Germany. Eur J Cancer. 6(7):176.
Feng J, Yuen C, Jackson D. 2008. Cost-effectiveness of enoxaparin as prophylactic therapy versus unfractionated heparin or no prophylaxis in hospitalised medical patients. ISPOR 11th Annual European Congress. 8–11 November 2008, Athens, Greece. Poster presentation.
Martin A, Cottrell S, Standaert B. 2008. Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK. J Med Economics. 11(3): 471–484.
Mazzaglia G, Yurgin N, Boye KS, Trifirò G, Cottrell S, Allen E, Filippi A, Medea G, Cricelli C. 2008. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4 year retrospective study from national primary care data. Pharmacol Res. 57(5):358–63.
Medical Services Advisory Committee. 2008. Endoscopic ultrasound guided fine-needle aspiration for the staging of non-small cell lung cancer and the diagnosis of mediastinal masses. May 2007. Assessment report. Department of Health and Ageing, Commonwealth of Australia. Canberra.
Perez D, Cotter T, Makino K, Bhatti T, Gordois A, Guarnieri C, Lewis S, Glass P, Bishop J. 2008. Pharmacotherapy evaluation: drugs that assist smoking cessation. Sydney: Cancer Institute NSW. October 2008.